Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-014054)

Filing Details

Accession Number:: 0001179110-14-014054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-10 17:13:34
Reporting Period:: 2014-09-08

Filing Date:: 2014-09-10
Accepted Time:: 2014-09-10 17:13:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1578845	Actavis Plc	ACT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337012	Iii Albert Paonessa	1 Grand Canal Square, Docklands Dublin 2 L2 00000	President Anda, Inc.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.0001	Disposition	2014-09-08	6,642	$230.49	21,856	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.45 to $230.62, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (1) of this Form 4.